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Abstract
Background: Environmental monitoring of airborne filamentous fungi is necessary to reduce fungal concentrations
in operating theaters and in controlled environments, and to prevent infections. The present study reports results of
a surveillance of filamentous fungi carried out on samples from air and surfaces in operating theaters and
controlled environments in an Italian university hospital.
Methods: Sampling was performed between January 2010 and December 2012 in 32 operating theaters and five
departments with high-risk patients. Indoor air specimens were sampled using a microbiological air sampler; Rodac
contact plates were used for surface sampling. Fungal isolates were identified at the level of genera and species.
Results: Sixty-one samples (61/465; 13.1%) were positive for molds, with 18 from controlled environments (18/81;
22.2%) and 43 (43/384; 11.2%) from operating theaters. The highest air fungal load (AFL, colony-forming units per
cubic meter [CFU/m3]) was recorded in the ophthalmology operating theater, while the pediatric onco-hematology
ward had the highest AFL among the wards (47 CFU/m3). The most common fungi identified from culture of air
specimens were Aspergillus spp. (91.8%), Penicillium spp., (6%) and Paecilomyces spp. (1.5%). During the study period,
a statistically significant increase in CFU over time was recorded in air-controlled environments (p = 0.043), while
the increase in AFL in operating theaters was not statistically significant (p = 0.145). Molds were found in 29.1% of
samples obtained from surfaces. Aspergillus fumigatus was the most commonly isolated (68.5%).
Conclusions: Our findings will form the basis for action aimed at improving the air and surface quality of these
special wards. The lack of any genetic analysis prevented any correlation of fungal environmental contamination
with onset of fungal infection, an analysis that will be undertaken in a prospective study in patients admitted to
the same hospital.
Keywords: Contamination, Fungi, Hospital, Air, Surfaces, Environment
Background
Pathogenic or opportunist microorganisms in hospital
environments may be a source of infection in susceptible
hosts [1,2]. This is particularly worrying in controlled
environments with immunocompromised patients [3-5]
and in operating theaters where numerous risk factors
may exist, including inefficient ventilation systems and
failure to follow infection control behaviors in healthcare
workers [6,7].
The air and surfaces in high-risk environments have
been often studied as a source of bacterial infection
[8-10], but regarding fungal contamination, the literature
data are still limited [11-14]. The most common infec-
tion in fatal complications is aspergillosis in patients
with hematological malignancies [15] and mucormycosis
in patients with uncontrolled diabetes mellitus [16,17].
Rare mold diseases, such as fusariosis and scedosporio-
sis, have also been described [18-20]. Filamentous fungal
infections (FFIs) are serious postoperative complications
in transplant recipients [21,22], requiring particular at-
tention by the clinician and surgeon.
Although the actual incidence of FFIs has increased
worldwide, the real frequency is often underestimated
because of the difficulty in determining the cause. More-
over, the lack of standardized protocols and unclear
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reference threshold values complicates the analysis. The
aim of the present study was to analyze the presence of
molds in air and on surfaces in operating theaters and
controlled environments in a large hospital in southern
Italy and to assess the prevalence of the different species
that may affect the hospital indoor air quality.
Methods
Design study
This study was carried out from January 2010 to Decem-
ber 2012 in five controlled environments (intensive units
of wards admitting patients with a high risk of infection)
and 32 operating theaters of University Hospital, Apulia,
Southern Italy (UHSI). UHSI is a 1400-bed teaching hos-
pital providing all medical services, including a bone
marrow and solid organ transplantation service and 32
turbulent air flow operating theaters. According to hos-
pital safety protocols for controlled environments, air
and surface microbiological surveillance is performed
twice a year in operating theaters and once per year in
controlled environments. The 32 operating theaters in-
cluded eight general surgery, five specialist surgery, four
gynecology, four orthopedic, three ophthalmology, three
solid-organ transplantation, two otorhinolaryngology,
two pediatric, and one maxilla-facial surgery. Controlled
environments included a hematology unit (eight rooms),
a bone marrow transplant unit (six rooms), a solid-organ
transplantation unit (four rooms), a neonatal intensive
care unit (NICU) (four rooms), and a pediatric onco-
hematology unit (five rooms).
Air sampling
According to International Standard Organization (ISO
14698–1) [23] microbial standard procedures, air con-
tamination was evaluated by active sampling (SAS,
Aquaria Microflow, Milan, Italy) with a flow rate of
180 L/min. Because no air volume is recommended ei-
ther by the ISO or the Italian Institute for Occupational
Safety and Prevention [24], we sampled a suction vol-
ume of 500 L of air in one continuous drawing, based
on published data [25,6,26].
The sampler was placed about 1 m above the floor
and 1 m from the operating bed or the patient bed in
stay rooms. In each operating theater, sampling was
performed twice a year in the early morning before the
beginning of surgical activity (at rest) to verify the
efficiency of environmental cleaning systems and condi-
tioner systems and during surgical activity (in oper-
ational) to verify the anthropic impact on environmental
pollution. In the controlled environments, sampling was
performed once a year in the morning after the daily
cleaning. A total of 128 samples/year were collected in
the 32 operating theaters, of which 64 were at rest and
64 in operational, and 27 samples/year were collected
from the other controlled environments.
The presence of fungi was evaluated using plates con-
taining Sabouraud chloramphenicol dextrose agar (SabC,
Becton-Dickinson, Heidelberg, Germany). Each position
was simultaneously sampled by two plates that were in-
cubated for 10 days at 28° ±1°C. The number of colony-
forming units was adjusted using the conversion table
provided by the manufacturer and was expressed in
colony-forming units per cubic meter (CFU/m3). The
results were expressed as the mean of two plates in
colony-forming units. The air fungal load (AFL) was de-
fined as the number of captured CFU/m3 of air.
Surface sampling
Surface sampling was carried out using Rodac contact
plates contained Sabouraud dextrose agar with chloram-
phenicol and neutralizing agents (Merck, Grenoble; Becton
Dickinson, Rome) according to recommendations of
the European Standard - International Organization for
Standardization (EN ISO 14698–1) [23]. In controlled
environments, one sampling/year was performed at the
patient bedhead, wall, air-conditioning unit, night table,
and ventilator in all 27 selected rooms. In operating
theaters, two samplings/year were performed at the surgical
lamp, wall, air-conditioning, and table in all 32 selected
rooms. A total of 405 and 768 points were sampled in
controlled environments and operating theaters, respectively.
Each point was simultaneously sampled by two Rodac plates
that were incubated for 10 days at 28° ±1°C. The results were
expressed as the mean of two plates in colony-forming units
per square centimeter (CFU/cm2).
Fungal identification
Genus and species of the filamentous fungi isolates were
identified based on their macroscopic and microscopic
morphological features, in accordance with the methods
described by de Hoog [27].
The macroscopic examination was based on visual ob-
servation of morphological characteristics and color of
aerial mycelium, while the microscopic analysis was per-
formed by preparation of lactophenol cotton blue-
stained slides. The slides were prepared with tape that
adhered to aerial mycelium and placed on the lactophe-
nol cotton blue-stained slides.
Statistical analysis
Statistical analysis of data was performed using SPSS 10
for Mac OS X (SPSS Inc., Chicago, IL, USA). To assess
whether there was a time trend in the fungal contamin-
ation, a linear regression with the R2 test was fitted to
the data.




Overall, 465 air samples were collected: 81 from con-
trolled environments and 384 from operating theaters of
which 192 were at rest and 192 were in operational.
Sixty-one samples (61/465; 13.1%) were positive for
molds, 18 from controlled environments (18/81; 22.2%),
and 43 (43/384; 11.2%) from operating theaters. Filament-
ous fungi were isolated from air samples of two operating
theaters (ophthalmology and general surgery) and three
controlled environments (solid-organ transplantation unit,
neonatal intensive care unit, and the pediatric onco-
hematology unit) (Table 1). The highest air fungal load
(AFL; CFU/m3) was recorded in the ophthalmology oper-
ating theater with 61 CFU/m3 collected in operational,
while the highest AFL among the selected wards was in
the pediatric onco-hematology (47 CFU/m3) (Table 2). Of
402 CFU counted on cultures of all samples, Aspergillus
spp. was the most frequently recovered (369/402 CFU;
91.8%), followed by Penicillium spp., (24/402 CFU; 6%),
Paecilomyces spp. (6/402 CFU; 1.5%), Zygomycetes (2/
402 CFU; 0.5%), and Cladosporium spp. (1/441 CFU;
0.2%). The annual CFU of Aspergillus spp. showed an in-
crease from year 2010 to 2012 (R2 = 0.999; p = 0.03)
(Table 3, Table 4). A statistically significant increase over
time was recorded in controlled environments (R2 = 0.996;
p = 0.043), while the increase reported in the operating the-
aters was not statistically significant (R2 = 0.949; p = 0.145).
Surfaces
In total, 240 surfaces were sampled; 105 samples from
15 operating theatre rooms and 135 from 27 rooms of
the controlled environments. Overall, 70 (29.1%) were
positive for molds, 48 (68.5%) for Aspergillus fumigatus,
14 (20%) for Aspergillus niger, and 8 (11.4%) for Penicil-
lium notatum. The most contaminated surfaces were the
walls and the air conditioning units with a medium of
0.35 CFU/cm2 and 0.28 CFU/cm2, respectively.
Invasive fungal infections
During the period study, six cases of invasive fungal
infection in two high-risk departments were detected.
These cases were defined as probable aspergillosis ac-
cording to the criteria of the European Organization for
Research on the Treatment of Cancer/Mycoses Study
Group [28]. Aspergillus niger in two cases and Aspergil-
lus fumigatus in one case, were isolated from the sputum
of three patients. In the other three cases of aspergillosis,
the diagnosis of probable disease was based on clinical
and antigen tests (galactomannan assay).
Discussion
In hospital environments, airborne molds are a potential
risk for patients because of possible inhalation of conidia
Table 1 Number (No) of positive air samples in operating
theaters (OT) and controlled environments (CE) per year
Point of sampling No. of positive air samples/year
2010 2011 2012 Total
Ophthalmology (OT) 7/12 6/12 12/12 25/36
General surgery (OT) 0/32 8/32 10/32 18/96
Solid organ transplantation (CE) 0/4 2/4 3/4 5/12
NICU* (CE) 2/6 0/6 5/6 7/18
Pediatric onco-hematology (CE) 0/8 2/8 4/8 6/24
*NICU = Neonatal Intensive Care Unit.
Table 2 Fungal isolates recovered in air samples from the
operating theaters and controlled environments
Total CFU count*/year
Fungal isolates 2010 2011 2012 No %
Aspergillus spp. 80 125 164 369 91.8
Penicillium spp. 3 21 24 6
Paecilomyces spp. 6 6 1.5
Zygomycetes 2 2 0.5
Cladosporium spp. 1 1 0.2
Total 80 135 187 402 100
*The number of CFU counted on cultures of all samples obtained during study.
Table 3 Fungal species recovered in air samples from the
controlled environments
Total CFU count*/year
Fungal species 2010 2011 2012 N° %
Aspergillus niger 34 29 52 115 54
Aspergillus fumigatus 25 36 61 28.6
Aspergillus flavus 10 10 4.7
Penicillium notatum 2 15 17 8
Penicillium expansum 1 6 7 3.3
Mucor pusillus 1 1 0.5
Rhizopus arrhizus 1 1 0.5
Cladosporium herbarum 1 1 0.5
Total 34 68 111 213 100
*The number of CFU counted on cultures of all samples obtained during study.
Table 4 Fungal species recovered in air samples from the
operating theaters
Total CFU count*/year
Fungal species 2010 2011 2012 N %
Aspergillus fumigatus 46 47 51 144 76.2
Paecilomyces lilacinus 6 6 3.2
Aspergillus flavus 14 25 39 20.6
Total 46 67 76 189 100
*The number of CFU counted on cultures of all samples obtained during
the study.
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[29]. Because surgical procedures expose patients to in-
fective complications, the operating theater is considered
a complex habitat in which all sources of pollution have
to be kept under control [21,22]. In particular, the
widespread presence of Aspergillus spp. is the major
extrinsic risk factor for invasive aspergillosis, caused
by A. fumigatus and other species of Aspergillus, such
as A. flavus, A. niger, and A. terreus, depending on the
local epidemiology [30] and according to the season
[31]. In our study, the AFLs varied from 2 to 47
CFU/m3 in the controlled environments and from 0 to
61 CFU/m3 in operating theaters, with the highest
value reached during surgical procedures. Although we
also observed that the AFL varied throughout the year,
we could not correlate the data with seasons because
of the low number of samples.
The pediatric onco-hematology had the highest fungal
contamination, probably because of the presence of
more staff and others (parents, clowns to help conven-
tional therapy, and psychologists) or because of the nat-
ural migration of fungal spores on the clothes of people
coming from outside. This ward underwent partial re-
construction, which raised dust-rich Aspergillus spores
associated with the construction of nearby buildings, in-
ternal demolition, construction, and the renovation of
hospital wards. Systems for treating and humidifying air
can be easily colonized and create a reservoir of spores
in the indoor environment [32].
Studies seem to have confirmed a correlation between
Aspergillus concentration and cases of aspergillosis. Pini
et al. [33], during a surveillance of hematology wards,
found extremely low concentrations of A. fumigatus in
the rooms and corridors and no cases of invasive
aspergillosis. More recently, Pokala et al. [14] demon-
strated a correlation between a high number of air-
borne fungal spores and cases of invasive aspergillosis
in an onco-hematology pediatric ward that underwent
building renovations.
Conclusions
Although the presence of mold contamination in the
healthcare environment may increase fungal infections,
the lack of a genetic analysis on recovered strains pre-
vented any correlation analysis between clinical disease
and environmental isolates in our surveillance. However,
the isolation of fungal strains calls for more adequate con-
trol measures. Regular surveillance and cleaning along
with restriction of visitors might be among the measures
necessary to reduce or totally eliminate the fungal load
of indoor air. We are planning a prospective study fo-
cused on the correlation of fungal contamination with
cases of fungal disease by genetic analysis of clinical
and environmental strains, taking into account local
epidemiological data.
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